New Anaesthetic Nasal Spray Could Be Good News For Dental Patients

Sample News Big

A new anaesthetic nasal spray could spell good news for dental patients. The spray, which could replace lidocaine injections, is currently undergoing clinical trials.

The findings of the second stage of testing were published online in May and will be included in the July edition of the Journal of Dental Research. The second phase of the trial involved 45 adults and while the study was awaiting publication, researchers carried out the third and final phase of clinical trials.

The second and third phases of testing revealed successful results and it appears likely that the nasal spray will be approved by the US Food and Drug Administration. Author of the study, Sebastian Ciancio (DDS chair of Prosthodontics and Endodontics at the University of Buffalo) believes that the drug could be available next year.

In an interview, Dr Ciancio said that the spray could “change the way people get their dental work done.”

The drug has been formulated and developed at St Renatus,Fort Collinsand is known as Kovocaine Mist. It delivers the same level of anaesthesia as a lidocaine injection and could be particularly beneficial for patients who avoid going to the dentist because they have a phobia of needles.

The spray contains tetracaine and oxymetazoline hydrochloride, which is a decongestant, which helps to reduce inflammation and bleeding. The formula is based on medicines used by otolaryngologists.

Join this Discussion

Comments are closed.